Precautions for use of gemtuzumab/gemtuzumab (MYLOTARG)

Gemtuzumab/Gemtuzumab (MYLOTARG) is a drug used to treat acute myeloid leukemia (AML). Its unique targeted therapeutic mechanism makes it a promising treatment option. However, when using Gemtuzumab/Gemtuzumab, patients and doctors need to pay special attention to a series of matters to ensure the effectiveness and safety of the treatment. The following are some precautions for using Gemtuzumab/Gemtuzumab:

1. Physician’s supervision:Gemtuzumab/Gemtuzumab treatment should be carried out under the supervision of a physician. The doctor will develop a personalized treatment plan based on the patient's specific situation and regularly monitor the effectiveness of the treatment and the patient's health status.

2. Individualized treatment plan:Gemtuzumab/The dosage and treatment plan of gemtuzumab should be individually adjusted based on the patient's age, AML type and severity, general health status and other factors. There is no set dose that works for all patients, so your doctor's advice is crucial.

3. Understand the side effects:Gemtuzumab/Gemtuzumab may cause a series of side effects, including but not limited to fever, headache, nausea, vomiting, anemia, thrombocytopenia, leukopenia, abnormal liver function, etc. Patients need to be aware of these potential adverse reactions and promptly report any unusual symptoms to their doctor.

4. Immune system monitoring: BecauseGemtuzumab/Gemtuzumab attacks leukemia cells by activating the immune system, it may affect immune function. Patients need to undergo regular immune system monitoring to ensure that their immune system remains functioning properly during treatment.

5. Pregnancy and lactation:Gemtuzumab/Gemtuzumab may have effects on the fetus or infant. If the patient is pregnant or breastfeeding, gemtuzumab should be used before/span>gemtuzumab/Discuss the potential risks and benefits with your doctor beforehand to develop an appropriate treatment plan.

6. Diagnostic tests: During treatment, doctors may perform periodic blood tests and other diagnostic tests to monitor AML's response and disease progression. Patients need to follow their doctor's recommendations and have these tests on time.

7. Drug Interactions: Patients need to tell their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with Gemtuzumab/Gemtuzumab, affecting its efficacy or increasing the risk of side effects.

8. Pay attention to diet and lifestyle: Patients should maintain a healthy lifestyle during treatment, including a balanced diet, adequate rest and moderate exercise. Additionally, avoid exposure to environments and substances that may cause infection, as the immune system may be somewhat suppressed during treatment.

9. Understand the treatment plan: Patients and family members need to fully understand the treatment plan, including treatment cycles, medication frequency and dosage, etc. Education and support can help patients better cope with the challenges of treatment.

In short, Gemtuzumab/Gemtuzumab is an important drug for targeted therapy AML, but the above precautions need to be paid close attention to when using it. Close collaboration between patient and physician is key to ensuring successful treatment, so patients should feel free to raise any questions or concerns with their physician and actively participate in the treatment process.

Gemtuzumab/GemtuzumabIt is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channelsGemtuzumab/Gemtuzumab. Foreign Gemtuzumab/Gemtuzumab is only Pfizer’s original drug, which is expensive, and the cheaper ones are mainly Turkish original drugs. The price of the drug is around 45,000 yuan, and the price of the original drug in Hong Kong, China is around 65,000 yuan, and the ingredients and efficacy of the original drug are consistent.